This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rowe, T.
Right arrow Articles by Katz, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowe, T.
Right arrow Articles by Katz, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 1999, p. 937-943, Vol. 37, No. 4
0095-1137/99/$04.00+0

Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

Thomas Rowe,1 Robert A. Abernathy,1 Jean Hu-Primmer,1 William W. Thompson,1 Xiuhua Lu,1 Wilina Lim,2 Keiji Fukuda,1 Nancy J. Cox,1 and Jacqueline M. Katz1,*

Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and Government Virus Unit, Queen Mary Hospital, Department of Health, The Hong Kong Special Administrative Region, Hong Kong, People's Republic of China2

Received 17 September 1998/Returned for modification 9 November 1998/Accepted 6 January 1999

From May to December 1997, 18 cases of mild to severe respiratory illness caused by avian influenza A (H5N1) viruses were identified in Hong Kong. The emergence of an avian virus in the human population prompted an epidemiological investigation to determine the extent of human-to-human transmission of the virus and risk factors associated with infection. The hemagglutination inhibition (HI) assay, the standard method for serologic detection of influenza virus infection in humans, has been shown to be less sensitive for the detection of antibodies induced by avian influenza viruses. Therefore, we developed a more sensitive microneutralization assay to detect antibodies to avian influenza in humans. Direct comparison of an HI assay and the microneutralization assay demonstrated that the latter was substantially more sensitive in detecting human antibodies to H5N1 virus in infected individuals. An H5-specific indirect enzyme-linked immunosorbent assay (ELISA) was also established to test children's sera. The sensitivity and specificity of the microneutralization assay were compared with those of an H5-specific indirect ELISA. When combined with a confirmatory H5-specific Western blot test, the specificities of both assays were improved. Maximum sensitivity (80%) and specificity (96%) for the detection of anti-H5 antibody in adults aged 18 to 59 years were achieved by using the microneutralization assay combined with Western blotting. Maximum sensitivity (100%) and specificity (100%) in detecting anti-H5 antibody in sera obtained from children less than 15 years of age were achieved by using ELISA combined with Western blotting. This new test algorithm is being used for the seroepidemiologic investigations of the avian H5N1 influenza outbreak.


* Corresponding author. Mailing address: Influenza Branch, Mailstop G-16, DVRD, NCID, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Atlanta, GA 30333. Phone: (404) 639-3591. Fax: (404) 639-2334. E-mail: jmk9{at}cdc.gov.


Journal of Clinical Microbiology, April 1999, p. 937-943, Vol. 37, No. 4
0095-1137/99/$04.00+0



This article has been cited by other articles:

  • Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., Brammer, T. L., Cox, N. J., Tumpey, T. M., Katz, J. M. (2009). Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. NEJM 361: 1945-1952 [Abstract] [Full Text]  
  • Greenberg, M. E., Lai, M. H., Hartel, G. F., Wichems, C. H., Gittleson, C., Bennet, J., Dawson, G., Hu, W., Leggio, C., Washington, D., Basser, R. L. (2009). Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine -- Preliminary Report. NEJM 0: NEJMoa0907413v1-1 [Abstract] [Full Text]  
  • Clark, T. W., Pareek, M., Hoschler, K., Dillon, H., Nicholson, K. G., Groth, N., Stephenson, I. (2009). Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine -- Preliminary Report. NEJM 0: NEJMoa0907650v1-1 [Abstract] [Full Text]  
  • Kitphati, R., Pooruk, P., Lerdsamran, H., Poosuwan, S., Louisirirotchanakul, S., Auewarakul, P., Chokphaibulkit, K., Noisumdaeng, P., Sawanpanyalert, P., Puthavathana, P. (2009). Kinetics and Longevity of Antibody Response to Influenza A H5N1 Virus Infection in Humans. CVI 16: 978-981 [Abstract] [Full Text]  
  • Bastien, N., Bowness, D., Burton, L., Bontovics, E., Winter, A.-L., Tipples, G., Minielly, D., Gregg, B., Cramer, C., Schincariol, C., Li, Y. (2009). Parotitis in a Child Infected with Triple-Reassortant Influenza A Virus in Canada in 2007. J. Clin. Microbiol. 47: 1896-1898 [Abstract] [Full Text]  
  • Perrone, L. A., Ahmad, A., Veguilla, V., Lu, X., Smith, G., Katz, J. M., Pushko, P., Tumpey, T. M. (2009). Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge. J. Virol. 83: 5726-5734 [Abstract] [Full Text]  
  • Galli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., Malzone, C., Castellino, F., Gentile, C., McNally, T., Del Giudice, G., Banzhoff, A., Brauer, V., Montomoli, E., Zambon, M., Katz, J., Nicholson, K., Stephenson, I. (2009). Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. USA 106: 7962-7967 [Abstract] [Full Text]  
  • Laddy, D. J., Yan, J., Khan, A. S., Andersen, H., Cohn, A., Greenhouse, J., Lewis, M., Manischewitz, J., King, L. R., Golding, H., Draghia-Akli, R., Weiner, D. B. (2009). Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus. J. Virol. 83: 4624-4630 [Abstract] [Full Text]  
  • Fazekas, G., Martosne-Mendi, R., Jankovics, I., Szilvasy, I., Vajo, Z. (2009). Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains. CVI 16: 437-443 [Abstract] [Full Text]  
  • Noah, D. L., Hill, H., Hines, D., White, E. L., Wolff, M. C. (2009). Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure. CVI 16: 558-566 [Abstract] [Full Text]  
  • Katz, J. M., Veguilla, V., Belser, J. A., Maines, T. R., Van Hoeven, N., Pappas, C., Hancock, K., Tumpey, T. M. (2009). The public health impact of avian influenza viruses. Poult. Sci. 88: 872-879 [Abstract] [Full Text]  
  • Mahony, J. B. (2008). Detection of Respiratory Viruses by Molecular Methods. Clin. Microbiol. Rev. 21: 716-747 [Abstract] [Full Text]  
  • Ehrlich, H. J., Muller, M., Oh, H. M.L., Tambyah, P. A., Joukhadar, C., Montomoli, E., Fisher, D., Berezuk, G., Fritsch, S., Low-Baselli, A., Vartian, N., Bobrovsky, R., Pavlova, B. G., Pollabauer, E. M., Kistner, O., Barrett, P. N., the Baxter H5N1 Pandemic Influenza Vaccine Clinic, (2008). A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture. NEJM 358: 2573-2584 [Abstract] [Full Text]  
  • Ruat, C., Caillet, C., Bidaut, A., Simon, J., Osterhaus, A. D. M. E. (2008). Vaccination of Macaques with Adjuvanted Formalin-Inactivated Influenza A Virus (H5N1) Vaccines: Protection against H5N1 Challenge without Disease Enhancement. J. Virol. 82: 2565-2569 [Abstract] [Full Text]  
  • Wu, W. L., Chen, Y., Wang, P., Song, W., Lau, S.-Y., Rayner, J. M., Smith, G. J. D., Webster, R. G., Peiris, J. S. M., Lin, T., Xia, N., Guan, Y., Chen, H. (2008). Antigenic Profile of Avian H5N1 Viruses in Asia from 2002 to 2007. J. Virol. 82: 1798-1807 [Abstract] [Full Text]  
  • Peiris, J. S. M., de Jong, M. D., Guan, Y. (2007). Avian Influenza Virus (H5N1): a Threat to Human Health. Clin. Microbiol. Rev. 20: 243-267 [Abstract] [Full Text]  
  • Skowronski, D. M., Li, Y., Tweed, S. A., Tam, T. W.S., Petric, M., David, S. T., Marra, F., Bastien, N., Lee, S. W., Krajden, M., Brunham, R. C. (2007). Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ 176: 47-53 [Abstract] [Full Text]  
  • Kong, W.-p., Hood, C., Yang, Z.-y., Wei, C.-J., Xu, L., Garcia-Sastre, A., Tumpey, T. M., Nabel, G. J. (2006). Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc. Natl. Acad. Sci. USA 103: 15987-15991 [Abstract] [Full Text]  
  • Huber, V. C., McKeon, R. M., Brackin, M. N., Miller, L. A., Keating, R., Brown, S. A., Makarova, N., Perez, D. R., MacDonald, G. H., McCullers, J. A. (2006). Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza.. CVI 13: 981-990 [Abstract] [Full Text]  
  • Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., Wolff, M. (2006). Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.. NEJM 354: 1343-1351 [Abstract] [Full Text]  
  • Humberd, J., Guan, Y., Webster, R. G. (2006). Comparison of the Replication of Influenza A Viruses in Chinese Ring-Necked Pheasants and Chukar Partridges. J. Virol. 80: 2151-2161 [Abstract] [Full Text]  
  • Ansaldi, F., Bacilieri, S., Banfi, F., Durando, P., Sticchi, L., Icardi, G., Gasparini, R. (2006). Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses. CVI 13: 162-164 [Abstract] [Full Text]  
  • Ungchusak, K., Auewarakul, P., Dowell, S. F., Kitphati, R., Auwanit, W., Puthavathana, P., Uiprasertkul, M., Boonnak, K., Pittayawonganon, C., Cox, N. J., Zaki, S. R., Thawatsupha, P., Chittaganpitch, M., Khontong, R., Simmerman, J. M., Chunsutthiwat, S. (2005). Probable Person-to-Person Transmission of Avian Influenza A (H5N1). NEJM 352: 333-340 [Abstract] [Full Text]  
  • Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Basler, C. F. (2004). Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101: 3166-3171 [Abstract] [Full Text]  
  • Tumpey, T. M., Renshaw, M., Clements, J. D., Katz, J. M. (2001). Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection. J. Virol. 75: 5141-5150 [Abstract] [Full Text]  
  • Lu, X., Renshaw, M., Tumpey, T. M., Kelly, G. D., Hu-Primmer, J., Katz, J. M. (2001). Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination. J. Virol. 75: 4896-4901 [Abstract] [Full Text]  
  • Donatelli, I., Campitelli, L., Di Trani, L., Puzelli, S., Selli, L., Fioretti, A., Alexander, D. J., Tollis, M., Krauss, S., Webster, R. G. (2001). Characterization of H5N2 influenza viruses from Italian poultry. J. Gen. Virol. 82: 623-630 [Abstract] [Full Text]  
  • Horimoto, T., Kawaoka, Y. (2001). Pandemic Threat Posed by Avian Influenza A Viruses. Clin. Microbiol. Rev. 14: 129-149 [Abstract] [Full Text]